New Insights and Modern Treatment of AL Amyloidosis.
- Published in:
- Current Hematologic Malignancy Reports, 2013, v. 8, n. 4, p. 291, doi. 10.1007/s11899-013-0175-0
- By:
- Publication type:
- Article
Works matching IS 15588211 AND DT 2013 AND VI 8 AND IP 4
Results: 16
1
2
Genetic Basis of MPN: Beyond JAK2-V617F.
- Published in:
- Current Hematologic Malignancy Reports, 2013, v. 8, n. 4, p. 299, doi. 10.1007/s11899-013-0184-z
- By:
- Publication type:
- Article
3
New Approaches to Smoldering Myeloma.
- Published in:
- Current Hematologic Malignancy Reports, 2013, v. 8, n. 4, p. 270, doi. 10.1007/s11899-013-0174-1
- By:
- Publication type:
- Article
4
Multiple Myeloma: Defining the High-Risk Patient and Determining the Optimal Treatment Strategy.
- Published in:
- Current Hematologic Malignancy Reports, 2013, v. 8, n. 4, p. 277, doi. 10.1007/s11899-013-0183-0
- By:
- Publication type:
- Article
5
Management of Double-Refractory Multiple Myeloma.
- Published in:
- Current Hematologic Malignancy Reports, 2013, v. 8, n. 4, p. 253, doi. 10.1007/s11899-013-0173-2
- By:
- Publication type:
- Article
6
Allogeneic Hematopoietic Stem Cell Transplantation for Multiple Myeloma: What Place, If Any?
- Published in:
- Current Hematologic Malignancy Reports, 2013, v. 8, n. 4, p. 284, doi. 10.1007/s11899-013-0185-y
- By:
- Publication type:
- Article
7
Febrile Neutropenia in Hematologic Malignancies.
- Published in:
- Current Hematologic Malignancy Reports, 2013, v. 8, n. 4, p. 370, doi. 10.1007/s11899-013-0171-4
- By:
- Publication type:
- Article
8
Are MPNs Vascular Diseases?
- Published in:
- Current Hematologic Malignancy Reports, 2013, v. 8, n. 4, p. 307, doi. 10.1007/s11899-013-0176-z
- By:
- Publication type:
- Article
9
The New Landscape of Therapy for Myelofibrosis.
- Published in:
- Current Hematologic Malignancy Reports, 2013, v. 8, n. 4, p. 325, doi. 10.1007/s11899-013-0178-x
- By:
- Publication type:
- Article
10
Molecular Classification of Myeloproliferative Neoplasms—Pros and Cons.
- Published in:
- Current Hematologic Malignancy Reports, 2013, v. 8, n. 4, p. 342, doi. 10.1007/s11899-013-0179-9
- By:
- Publication type:
- Article
11
There’s Risk, and Then There’s RISK: The Latest Clinical Prognostic Risk Stratification Models in Myelodysplastic Syndromes.
- Published in:
- Current Hematologic Malignancy Reports, 2013, v. 8, n. 4, p. 351, doi. 10.1007/s11899-013-0172-3
- By:
- Publication type:
- Article
12
WHO Classification of Myeloproliferative Neoplasms (MPN): A Critical Update.
- Published in:
- Current Hematologic Malignancy Reports, 2013, v. 8, n. 4, p. 333, doi. 10.1007/s11899-013-0186-x
- By:
- Publication type:
- Article
13
Standardizing the Initial Evaluation for Myelodysplastic Syndromes.
- Published in:
- Current Hematologic Malignancy Reports, 2013, v. 8, n. 4, p. 361, doi. 10.1007/s11899-013-0180-3
- By:
- Publication type:
- Article
14
Incorporating Novel Agents in the Management of Elderly Myeloma Patients.
- Published in:
- Current Hematologic Malignancy Reports, 2013, v. 8, n. 4, p. 261, doi. 10.1007/s11899-013-0177-y
- By:
- Publication type:
- Article
15
Preclinical Models for Drug Selection in Myeloproliferative Neoplasms.
- Published in:
- Current Hematologic Malignancy Reports, 2013, v. 8, n. 4, p. 317, doi. 10.1007/s11899-013-0182-1
- By:
- Publication type:
- Article
16
When to Transplant MDS, and What to Do When Transplant Fails.
- Published in:
- Current Hematologic Malignancy Reports, 2013, v. 8, n. 4, p. 379, doi. 10.1007/s11899-013-0181-2
- By:
- Publication type:
- Article